ACL17SPG

ACL17SPG is a branded procedural epidural regional anesthesia kit rather than a single novel active pharmaceutical ingredient. Public drug-listing information identifies it as a **single-shot epidural kit** packaged by Clint Pharmaceuticals for anesthetic procedures, and available label text indicates the kit contains established local anesthetic drug products used for neuraxial anesthesia, including lidocaine hydrochloride, bupivacaine hydrochloride, and epinephrine-containing components. Because \"ACL17SPG\" denotes the kit configuration instead of one discrete chemical entity, its pharmacology derives from the included anesthetic agents: lidocaine and bupivacaine block voltage-gated sodium channels to inhibit nerve impulse conduction, while epinephrine acts as an adrenergic agonist that can prolong local anesthetic effect through vasoconstriction. The exact kit composition may vary by label configuration, so ACL17SPG is best treated as a specific combination procedural drug kit product.

Other names

ACL17SPG SINGLE SHOT EPIDURALACL-17SPG SINGLE SHOT EPIDURALACL 17SPG SINGLE SHOT EPIDURAL